Clinical Trial Update: First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of AZD9793 in patients with advanced or metastatic solid tumours is currently recruiting. The trial includes hepatocellular carcinoma as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AZD9793

Snippet

Sponsor: AstraZeneca | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: RECRUITING